Alex Knapp, Forbes Staff

Author's posts

This Company Just Raised $71 Million To See The Forest For The Trees Within A Patient’s Cells

Spatial biology startup Resolve Biosciences is building up capital to accelerate its development of ‘Genomics 3.0.’

InnovationRx: Zombie Mushrooms, Europe’s Covid Wave And Soft Brain Implants

InnovationRx is your weekly digest of healthcare news. Sign up!

Move Over, Elon: This Under 30 CEO Just Raised $8 Million To Build A Next-Generation Brain Implant

Paul Le Floch’s company, Axoft, is developing brain implants made from soft, flexible materials that reduce injury and could treat disorders such as cerebral palsy.

InnovationRx: Declining VC Investment In Digital Health; Plus: Long Covid’s Impact

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: Medicare Advantage Plans Are Expanding; Plus: A Medtech Billionaire

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: Mark Cuban’s Focusing On His Drug Company; Plus: Covid Cases On The Rise

InnovationRx is your weekly digest of healthcare news. Sign up!

Billionaire Scientist Timothy Springer Awarded 2022 Lasker Prize For Basic Research

The award, which he shares with two others, is for a set of discoveries in the 1970s that form the basis for new drug treatments today.

2023 Breakthrough Prizes Announced: Deepmind’s Protein Folders Awarded $3 Million

The same AI engine that made computers even better at games like Chess and Go could also boost new drug discoveries.

InnovationRx: Fed Rate Hikes Are Bad For Biotech; Plus: A New Covid Variant Wave?

InnovationRx is your weekly digest of healthcare news. Sign up!

InnovationRx: Biden Boosts Biotech Manufacturing; Plus: A Covid Pandemic ‘Finish Line’

InnovationRx is your weekly digest of healthcare news. Sign up!